Abstract

Utility of111In-octreotide for the Characterization of an Extra-axial Lesion with uptake of 18F-choline PET-CT in a Patient with Adenocarcinoma of the Prostate

Highlights

  • We present a patient with prostate adenocarcinoma in whose evolution presented a biochemical relapse and the finding of 18F-choline uptake in an extra-axial brain lesion located in clivus with no conclusive Magnetic Resonance Imaging (MRI) for metastases

  • Given the findings of 18F-choline Positron Emission Tomography (PET)-Computed Tomography (CT), brain MRI and confirmed biochemical progression resistant to castration, the case was evaluated in the Neuro-Oncology Tumors Committee of our center, which decided to perform a SPECT-CT with 111In-octreotide to be able to clarify the differential diagnosis between a brain metastasis or meningioma in this location

  • The high ratio between phosphocholine and glycerophosphocholine is responsible for cellular transformation and cell immortalization and, in addition, this ratio is higher in atypical meningiomas [8]

Read more

Summary

Background

Meningiomas account approximately 20% of primary brain tumors and nearly 1-2% are incidentally postmortem findings. In the context of a biochemical relapse in prostate adenocarcinoma and a single 18F-choline uptake in the brain, the differential diagnosis between a meningioma and a possible brain metastasis may be difficult. Numerous publications have reported overexpression of somatostatin receptors in meningiomas and the usefulness of 111In-octreotide in the non-invasive differential diagnosis of this type of lesions [7]. There are no conclusive data in the literature about an uptake of 111In-octreotide in brain metastases, except for tumors of neuroendocrine strain or with somatostatin receptors overexpression. We present a patient with prostate adenocarcinoma in whose evolution presented a biochemical relapse and the finding of 18F-choline uptake in an extra-axial brain lesion located in clivus with no conclusive MRI for metastases. Our findings highlight the relevance and clinical implication derived from the performance of a cerebral SPECT-CT with 111In-octreotide to the lesion characterization

Case report
Findings
Discussion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.